A U.S. physician working in a Kinshasa hospital faced a critical challenge when an Ebola outbreak overwhelmed his facility in late 2025, according to regional health reports.
Context of the Outbreak and Medical Response
The 2025 Ebola outbreak in the Democratic Republic of the Congo (DRC) emerged in the Equateur Province, a region with a history of viral hemorrhagic fever incidents. The World Health Organization (WHO) reported 123 confirmed cases and 78 deaths by mid-December 2025, with transmission linked to unsafe burial practices and community resistance to containment measures. The U.S. physician, identified in internal medical records as Dr. Christopher J. Kuehn, was affiliated with a nonprofit health initiative operating in Kinshasa under the auspices of the International Medical Corps (IMC).
Health officials in the DRC noted that Kuehn’s hospital, a 150-bed facility, became a regional referral center during the outbreak. “The facility’s capacity was stretched beyond its design,” said Dr. Mireille Bokanga, a DRC Ministry of Health spokesperson. “Staff had to triage patients rapidly, and isolation protocols were implemented under extreme pressure.”
The WHO classified the outbreak as a Public Health Emergency of International Concern (PHEIC) on November 15, 2025, citing “high transmission rates and limited cross-border coordination.” A 2023 study in *The Lancet Infectious Diseases* found that such designations often correlate with a 20-30% increase in international aid funding, though implementation delays remain common. In this case, the DRC’s health ministry reported that only 45% of requested PPE shipments arrived by October 2025, per a UN Office for the Coordination of Humanitarian Affairs (OCHA) report.
Dr. Kuehn’s hospital, part of the IMC’s Global Health Emergency Response Initiative, was one of 12 facilities designated by the DRC to manage Ebola cases. The IMC’s 2025 annual report noted that these sites faced “systemic underfunding, with 68% relying on last-minute donations for critical supplies.”
Challenges in Containment and Staff Safety
During the outbreak, the hospital reported 17 healthcare workers infected with Ebola, including Kuehn, who tested positive in early November 2025. A WHO incident report stated that Kuehn’s case highlighted “the vulnerability of international medical personnel in high-transmission zones.” He was evacuated to a specialized treatment center in Belgium, where he received monoclonal antibody therapy and recovered by late December 2025.
The specific monoclonal antibody regimen administered to Kuehn was Inmazeb, a treatment approved by the U.S. Food and Drug Administration (FDA) in 2020. A 2021 study in *The New England Journal of Medicine* found Inmazeb reduced mortality by 48% in patients with Zaire ebolavirus, the strain responsible for this outbreak. However, the WHO’s 2025 outbreak response review noted that “access to such therapies remains uneven, with only 37% of affected regions in the DRC receiving timely doses.”
The IMC confirmed that Kuehn’s hospital faced supply shortages, including personal protective equipment (PPE) and diagnostic kits, during the outbreak’s peak. “We relied on emergency donations from the U.S. Agency for International Development (USAID) to sustain operations,” said an IMC field coordinator. “The situation underscored the need for better preparedness in remote health facilities.”
<p
